Top Markets
#1 ICON ICON +273.37%
#2 ZetaChain ZetaChain +46.56%
#3 Four Four +45.47%
#4 Mubarak Mubarak +35.43%
#5 Phala Phala +32.67%
#6 World Mobile Token World Mobile Token +32.43%
#7 Bitway Bitway +25.67%
#8 PumpMeme PumpMeme +24.26%
#9 Pepe Pepe +24.25%
#10 AIOZ Network AIOZ Network +23.43%
Coin of the day
ICON ICON
Settings
Language
ENGLISH
Currency
USD
Theme
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rank in Stocks #832
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Share Price
$71.25
Market Cap
$29.87B
Change (1 day)
-0.34%
Change (1 year)
-51.16%
Country
US
Trade Zoetis Inc. (ZTS)

Category

Healthcare
P/S ratio for Zoetis Inc. (ZTS)
P/S ratio as of September 2026 TTM: 3.25
According to Zoetis Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.25. At the end of 2023 the company had a P/S ratio of 10.65.
P/S ratio history for Zoetis Inc. from 2009 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 3.25 -59.43%
2024 8.00 -24.95%
2023 10.65 25.27%
2022 8.50 -42.87%
2021 14.89 26.27%
2020 11.79 16.63%
2019 10.11 42.50%
2018 7.09 6.67%
2017 6.65 22.50%
2016 5.43 8.03%
2015 5.03 11.53%
2014 4.51 25.73%
2013 3.58 0.22%
2012 3.58 2.09%
2011 3.50 -15.38%
2010 4.14 -22.95%
2009 5.37 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.45 314.39%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.55 101.93%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.18 121.26%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 43.53%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.39 65.99%
US